CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals

[摘要] Tere have been recent reports of haemorrhage, blood clots and thrombocytopenia following administration of CoViD-19 vaccines that have raised concerns over the safety of genetic vaccines for people with pre-existing coagulation disorders or those on certain medications. Tis had also led to temporary suspension of Oxford/AZ CoViD vaccine in a number of countries across Europe [1]. As a result, Medicine and Healthcare Regulatory Authority, UK (MHRA) and European Medicines Agency (EMA) initiated a rigorous scientifc review of pharmacovigilance data and available evidence to assess the potential association of the vaccine to recent thrombotic events.

[学科分类] 药理学